Results for tag: "Coronary Microvascular Dysfunction Drug"

The Coronary Microvascular Dysfunction Drug market is a subset of the Cardiovascular Drugs market. It focuses on drugs used to treat coronary microvascular dysfunction (CMD), a condition that affects the small arteries in the heart. CMD can lead to chest pain, shortness of breath, and other symptoms. Treatment options include lifestyle changes, medications, and procedures. Common medications used to treat CMD include calcium channel blockers, beta blockers, and angiotensin-converting enzyme (ACE) inhibitors. The Coronary Microvascular Dysfunction Drug market is highly competitive, with many companies offering products to treat CMD. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more